FORGOT YOUR DETAILS?

LINK Pharmaceuticals Acquisition

by / Tuesday, 20 May 2008 / Published in News

LINK Pharmaceuticals today announced the transfer of the Akineton, Erythocin IV and the EES (erythromycin) product range from Abbott Australia.

This transfer is the result of LINK’s on-going partnership with the UK company Amdipharm.

Amdipharm recently completed the acquisition of these products from Abbott for several international markets and LINK will market them in Australia on Amdipharm’s behalf.

TOP